Title: Oligomeric Compounds Effecting Drosha-Mediated Cleavage
Filed: Sept. 20, 2005
Lead Inventor: Richard Griffey, Isis Pharmaceuticals
The invention, the patent application's abstract states, "provides methods of promoting Drosha-mediated cleavage of antisense oligomeric compounds and compositions and compounds for carrying out the same."
Title: Therapeutic Alteration of Transplantable Tissues Through In Situ or Ex Vivo Exposure to RNA Interference Molecules